How Fragile We Are: Influence of Stimulator of Interferon Genes (STING) Variants on Pathogen Recognition and Immune Response Efficiency.


Journal

Journal of chemical information and modeling
ISSN: 1549-960X
Titre abrégé: J Chem Inf Model
Pays: United States
ID NLM: 101230060

Informations de publication

Date de publication:
27 06 2022
Historique:
pubmed: 9 6 2022
medline: 29 6 2022
entrez: 8 6 2022
Statut: ppublish

Résumé

The stimulator of interferon genes (STING) protein is a cornerstone of the human immune response. Its activation by cGAMP in the presence of cytosolic DNA stimulates the production of type I interferons and inflammatory cytokines. In the human population, several STING variants exist and exhibit dramatic differences in their activity, impacting the efficiency of the host defense against infections. Understanding the molecular mechanisms of these variants opens perspectives for personalized medicine treatments against diseases such as viral infections, cancers, or autoinflammatory diseases. Through microsecond-scale molecular modeling simulations, contact analyses, and machine learning techniques, we reveal the dynamic behavior of four STING variants (wild type, G230A, R293Q, and G230A/R293Q) and rationalize the variability of efficiency observed experimentally. Our results show that the decrease in STING activity is linked to a stiffening of key structural elements of the binding cavity together with changes in the interaction patterns within the protein.

Identifiants

pubmed: 35675714
doi: 10.1021/acs.jcim.2c00315
doi:

Substances chimiques

Membrane Proteins 0
Interferons 9008-11-1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3096-3106

Auteurs

Jeremy Morere (J)

Université de Lorraine and CNRS, LPCT UMR 7019, F-54000 Nancy, France.

Cécilia Hognon (C)

Université de Lorraine and CNRS, LPCT UMR 7019, F-54000 Nancy, France.

Tom Miclot (T)

Université de Lorraine and CNRS, LPCT UMR 7019, F-54000 Nancy, France.
Department of Biological, Chemical and Pharmaceutical Sciences, Universita degli Studi di Palermo, via delle Scienze, 90126 Palermo, Italy.

Tao Jiang (T)

Université de Lyon, ENS de Lyon, CNRS UMR 5182, Laboratoire de Chimie, F-69342 Lyon, France.

Elise Dumont (E)

Université de Lyon, ENS de Lyon, CNRS UMR 5182, Laboratoire de Chimie, F-69342 Lyon, France.
Institut Universitaire de France, 5 rue Descartes, F-75005 Paris, France.

Giampaolo Barone (G)

Department of Biological, Chemical and Pharmaceutical Sciences, Universita degli Studi di Palermo, via delle Scienze, 90126 Palermo, Italy.

Antonio Monari (A)

Université de Lorraine and CNRS, LPCT UMR 7019, F-54000 Nancy, France.
Université Paris Cité and CNRS, ITODYS, F-75006, Paris, France.

Emmanuelle Bignon (E)

Université de Lorraine and CNRS, LPCT UMR 7019, F-54000 Nancy, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH